NEW YORK (GenomeWeb) — OpGen said today that it expects to post a 36 percent drop in its third quarter revenues amid a drop in sales of its QuickFISH rapid pathogen diagnostic products.

For the three months ended Sept. 30, OpGen reported preliminary unaudited revenues of $550,000 versus $750,000 in the same period last year — a decline the Gaithersburg, Maryland-based company attributed to lower QuickFISH revenues.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Jan
30
Sponsored by
Loop Genomics

This webinar will provide a comparison of several next-generation sequencing (NGS) approaches — including short-read 16S, whole-genome sequencing (WGS), and synthetic long-read sequencing technology — for use in microbiome research studies.

Feb
21
Sponsored by
L7 Informatics

This webinar will provide a first-hand look at how Gradalis, a clinical-stage immunotherapy developer, is using an information management solution from L7 to streamline its research, clinical, and manufacturing operations.